Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility

Sentinel node biopsy (SNB) for prostate cancer (PCa) represents an innovative technique aimed at improving nodal staging accuracy. The routinary adoption of this procedure in patients undergoing radical prostatectomy (RP) might be crucial to identify candidates who could effectively benefit from ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossin, Giulio, Zorzi, Federico, De Pablos-Rodríguez, Pedro, Biasatti, Arianna, Marenco, Josè, Ongaro, Luca, Perotti, Alessandro, Tulone, Gabriele, Traunero, Fabio, Piasentin, Andrea, Gomez-Ferrer, Alvaro, Zucchi, Alessandro, Trombetta, Carlo, Simonato, Alchiede, Rubio-Briones, José, Bartoletti, Riccardo, Ramírez-Backhaus, Miguel, Claps, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416990/
https://www.ncbi.nlm.nih.gov/pubmed/37568905
http://dx.doi.org/10.3390/diagnostics13152543
Descripción
Sumario:Sentinel node biopsy (SNB) for prostate cancer (PCa) represents an innovative technique aimed at improving nodal staging accuracy. The routinary adoption of this procedure in patients undergoing radical prostatectomy (RP) might be crucial to identify candidates who could effectively benefit from extensive pelvic lymph nodal dissection (ePLND). Despite some promising results, SNB for PCa is still considered experimental due to the lack of solid evidence and procedural standardization. In this regard, our narrative review aimed to analyze the most recent literature in this field, providing an overview of both the diagnostic accuracy measures and the oncological outcomes of SNB.

Ejemplares similares